Ownership as of February 10, 2023. Ten largest shareholders.
NameSeries A sharesSeries B sharesShare capital %Voting rights %
ANNWALL & ROTHSCHILD INVESTMENTS AB377 736510 4788.0929.31
SIX SIS AG, W8IMY01 194 86110.648.17
FJÄRDE AP-FONDEN01 120 0009.987.66
SWEDBANK ROBUR NY TEKNIK BTI0540 0004.813.69
AMF AKTIEFOND SMÅBOLAG0501 5854.473.43
TREDJE AP-FONDEN0501 5794.473.43
SKANDINAVISKA ENSKILDA BANKEN AB, W8IMY0347 6733.102.38
ÅLANDSBANKEN ABP0331 3902.952.27
UNIONEN0322 1962.872.20
DANGOOR, DAVID0306 4212.732.10
Sub-total377 7365 676 18354.1164.64
Other shareholders05 172 26545.8935.36
Total377 73610 848 448100.00100.00
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 377,736 class A shares with 10 votes per share and 10,848,448 class B shares with one vote per share, in total 11,226,184 shares.